Evaluation of HBV-DNA Monitoring after Completion of Chemotherapy using a PDCA Cycle following Introduction of a Support System Provided by a Multidisciplinary Team of Quality Management in Cancer Medicine. J. Can. Res. Updates [Internet]. 2025 Dec. 9 [cited 2026 Apr. 20];14:218-23. Available from: https://neoplasiaresearch.com/index.php/jcru/article/view/912